Neurocutaneous syndromes
Clinical Child Neurology, Page: 327-355
2020
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures5
- Readers5
Book Chapter Description
Neurocutaneous syndromes comprise diagnoses that affect the nervous system and skin on the basis of common embryologic origin from ectoderm. Abnormal cell proliferation and organization can manifest as tumor potential or vascular abnormalities in multiple locations; these can produce symptoms across the life span. An understanding of the natural history has guided recommendations to screen affected individuals and at-risk family members. With increasing research at a genetic and pathophysiologic level, there has been improved availability of treatment options not only for these specific conditions but others as well.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85089632686&origin=inward; http://dx.doi.org/10.1007/978-3-319-43153-6_13; https://link.springer.com/10.1007/978-3-319-43153-6_13; https://dx.doi.org/10.1007/978-3-319-43153-6_13; https://link.springer.com/chapter/10.1007/978-3-319-43153-6_13
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know